Pmd31 - The Concordance and Budget Impact of Multiple Er, Pr and Her2 Determinations in Dutch Breast Cancer Patients

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.1480
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Breast Cancer Subtypes Among Iraqi Patients: Identified by Their ER, PR and HER2 Status

Journal of the faculty of medicine baghdad
2017English

Results of 1-Year Diet and Exercise Interventions for ER+/PR+-/HER2- Breast Cancer Patients Correlated With Treatment Type

Chirurgia (Bucharest, Romania : 1990)
Surgery
2017English

Performance of Automated Scoring of ER, PR, HER2, CK5/6 and EGFR in Breast Cancer Tissue Microarrays in the Breast Cancer Association Consortium

The Clinical Journal of Pathology
2014English

Review of HER2 Immunohistochemistry and in Situ Hybridisation Concordance in Breast Cancer

Pathology
Forensic MedicinePathology
2020English

Is There a Role of Breast Pathologist in Diagnostic Challenges of Discordances in ER, PR, and HER2 Between Primary Breast Cancer and Brain Metastasis?

Journal of Neuro-Oncology
Cancer ResearchOncologyNeurology
2018English

Pcn74 - A Budget-Impact Analysis of Adjuvant Pertuzumab and Trastuzumab in Early Her2-Positive Breast Cancer

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Prognostic Impact of ANX7-GTPase in Metastatic and HER2-Negative Breast Cancer Patients

Clinical Cancer Research
Cancer ResearchOncology
2004English

Brain Metastases in Asian HER2-positive Breast Cancer Patients: Anti-Her2 Treatments and Their Impact on Survival

British Journal of Cancer
Cancer ResearchOncology
2012English

EXPRESSION OF ER, PR AND HER2/neu IMMUNOMARKERS IN INFILTRATING DUCT CARCINOMA BREAST IN CELL BLOCK PREPARATIONS AS COMPARED TO HISTOPATHOLOGY

Journal of Evolution of Medical and Dental Sciences
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy